327 related articles for article (PubMed ID: 29798691)
1. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
2. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
[TBL] [Abstract][Full Text] [Related]
3. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
4. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1 and drug abuse.
Wu R; Liu J; Li JX
Adv Pharmacol; 2022; 93():373-401. PubMed ID: 35341572
[TBL] [Abstract][Full Text] [Related]
7. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
8. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
Pei Y; Asif-Malik A; Canales JJ
Front Neurosci; 2016; 10():148. PubMed ID: 27092049
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges.
Berry MD; Gainetdinov RR; Hoener MC; Shahid M
Pharmacol Ther; 2017 Dec; 180():161-180. PubMed ID: 28723415
[TBL] [Abstract][Full Text] [Related]
11. Recognition of methamphetamine and other amines by trace amine receptor TAAR1.
Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F
Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377
[TBL] [Abstract][Full Text] [Related]
12. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
13. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
14. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
15. Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process.
Cichero E; Tonelli M
Future Med Chem; 2017 Sep; 9(13):1507-1527. PubMed ID: 28791911
[TBL] [Abstract][Full Text] [Related]
16. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1].
Zhang XQ; Li JT; Si TM; Su YA
Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099
[TBL] [Abstract][Full Text] [Related]
17. TAAR1 and Psychostimulant Addiction.
Liu J; Wu R; Li JX
Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
[TBL] [Abstract][Full Text] [Related]
18. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
[TBL] [Abstract][Full Text] [Related]
19. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
20. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
Chiellini G; Bellusci L; Sabatini M; Zucchi R
Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
